Evidence map›Paper›PMID 40403749›Full record

ArticleBiomedical physics & engineering express2025

The proton therapy research beamline at the Christie NHS foundation trust.

Nicholas T Henthorn, John-William Warmenhoven, Samuel P Ingram, Samuel P Manger, Michael J Merchant, Hywel Owen, Ranald I Mackay, Karen J Kirkby, Michael J Taylor

Abstract read
In one paragraph

Article in Biomedical physics & engineering express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nicholas T HenthornDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0002-9670-7638
John-William WarmenhovenDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0002-3638-7759
Samuel P IngramDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0002-1786-349X
Samuel P MangerDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0002-4475-2066
Michael J MerchantDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0001-8422-5255
Hywel OwenThe Cockcroft Institute, Warrington, United Kingdom.ORCID 0000-0001-5028-2841
Ranald I MackayDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Karen J KirkbyDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0002-0901-210X
Michael J TaylorDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.ORCID 0000-0002-8718-3684

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proton therapy is a relatively new modality for cancer treatment and has several open research questions, particularly in the biological realm. Due to large infrastructure costs the modality is reserved for specialist treatment, limiting the patient outcome dataset. This requires supplementation with fundamental research through

Indexed as

NeoplasmsProton TherapyCalibrationHumansMonte Carlo MethodRadiotherapy DosageUnited Kingdomirradiation facilitymedical physicsproton therapyradiobiology

Identifiers

PMID40403749
PMCPMC12296266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.